ATM Protein and p53 Phosphorylation in Ataxia-Telangiectasia Patients
Author Information
Author(s): Delia D, Mizutani S, Panigone S, Tagliabue E, Fontanella E, Asada M, Yamada T, Taya Y, Prudente S, Saviozzi S, Frati L, Pierotti M A, Chessa L
Primary Institution: Department of Experimental Oncology, Istituto Nazionale Tumori, Milano, Italy
Hypothesis
The study investigates the expression of ATM protein and its correlation with radiation responses in ataxia-telangiectasia patients and heterozygotes.
Conclusion
The study found that ataxia-telangiectasia patients have limited ATM protein expression, which does not support normal ATM-dependent responses.
Supporting Evidence
- The full-length ATM protein was detected in eight of 18 AT cases at 1–32% of normal levels.
- A truncated ATM protein was detected in a single case despite truncation mutations being common.
- Among ten asymptomatic heterozygous carriers, normal ATM levels were found in one and reduced by 40–50% in others.
- Radiation-induced phosphorylation of p53 was defective in AT and A(-T) cases and in 2/4 heterozygous carriers.
- The G1 cell cycle checkpoint was disrupted in all AT and A(-T) cases, and in 3/10 AT heterozygotes.
Takeaway
This study looked at how a protein related to DNA damage is made in people with a specific genetic condition, finding that they don't make enough of it to help with DNA repair.
Methodology
The study characterized ATM protein expression in immortalized cells from AT patients and correlated it with radiation responses.
Participant Demographics
The study included ataxia-telangiectasia patients, ataxia without telangiectasia cases, and asymptomatic heterozygous carriers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website